Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, is a common clinical presentation with a broad differential diagnosis. Its evaluation and management can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to understanding and managing syncope for healthcare professionals.
Syncope can be categorized into three broad categories: reflex, orthostatic hypotension, and cardiac. Reflex syncope, also known as neurally mediated syncope, includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension is caused by a drop in blood pressure upon standing. Cardiac syncope can be due to arrhythmias or structural heart disease.
A thorough history and physical examination are paramount in the evaluation of syncope. Specific attention should be given to the circumstances surrounding the syncopal event, including prodromal symptoms, position during the event, and recovery period. Diagnostic tests should be guided by clinical suspicion based on the history and physical examination.
The management of syncope depends on the underlying cause. Reflex syncope is usually managed with lifestyle modifications and reassurance. Orthostatic hypotension may require medication adjustments, volume expansion, and physical counterpressure maneuvers. Cardiac syncope may necessitate medical or surgical interventions, including pacemaker implantation or cardiac ablation.
Syncope is a complex clinical entity that requires a comprehensive approach for effective evaluation and management. A thorough understanding of its etiology, pathophysiology, clinical evaluation, and management strategies is essential for healthcare professionals to ensure optimal patient care.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation